PQUS0.390%
as of Jul 21
MRSH
GrowthMarsh & McLennan Cos Inc
Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. The company operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services.
Close · 3M
+1.18%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals4
Win rate100% (4/4)
Avg buy return+10.11%
PQUS · Weight decrease · 2d
MRSH currently sits at $182.15, 85% of its 52-week high, experiencing a +15.8% return over the last 30 days after a prior year saw a -15.3% decline. This recent, rapid price appreciation for Marsh & McLennan Cos Inc likely prompted PQUS’s AI ranking system, which manages a US large-cap portfolio with measured turnover, to reassess the stock's relative attractiveness. Despite MRSH's 9.87% revenue growth and a 25.91% ROE, the AI likely factored in the stock’s current PER of 22.0 and PBR of 5.86, alongside the swift price rise, leading to a consecutive weight decrease from 0.44% to 0.38% within the fund over the specified period. Such adjustments are consistent with PQUS's periodic rebalancing and layering of sector-balance and concentration rules, indicating a re-calibration of the position rather than an immediate exit based on the recent price action.
weight 0.440% → 0.380% (-0.060 pp)·stock up 9.2% in the 30 days before
Jul 17·entry $182.18·now $182.10
-0.04%
since Jul 17
PQUS · Weight decrease · 2d
MRSH currently trades at $172.14, sitting at 78% of its 52-week high, reflecting a -19.7% return over the past year despite a recent +3.7% gain in 30 days. This price context, coupled with a -2.7% 90-day return, likely influenced PQUS's AI ranking system to execute a minor weight decrease for Marsh & McLennan Cos Inc. The AI, which applies sector-balance and concentration rules to its US large-cap universe during periodic rebalances, adjusted MRSH's allocation from 0.43% to 0.42% over July 1st and 2nd. This measured reduction suggests the AI's assessment of MRSH's valuation, including a PER of 21.53 and PBR of 5.86, or its recent price trajectory, resulted in a slightly lower relative ranking despite the company's 9.87% revenue growth and 25.91% ROE.
weight 0.440% → 0.420% (-0.020 pp)·stock up 10.6% in the 30 days before
Jul 2·entry $178.54·now $182.10
+1.99%
since Jul 2
PQUS · Weight increase · 2d
MRSH's 25.91% Return on Equity and 9.87% Revenue Growth suggest a quality large-cap constituent, likely scoring well within Pictet Asset Management's AI ranking system, which identifies US large-cap companies. Despite its solid operational metrics, the stock's year-long price decline of 26.1% and its current position near the lower end of its $157.32 to $219.67 52-week range presented an opportunity for the AI. The consecutive weight increase on June 25th and 26th, raising MRSH's allocation from 0.41% to 0.43%, indicates the AI system likely re-evaluated the stock favorably at a price point close to its 52-week low. This measured increment in allocation aligns with PQUS's approach of integrating an AI ranking system with sector-balance and concentration rules, selectively increasing exposure to a US large-cap company like MRSH based on its underlying financial strength at a favorable valuation.
weight 0.410% → 0.430% (+0.020 pp)·stock up 5.3% in the 30 days before
Jun 26·entry $169.03·now $182.10Drifting
+7.73%
since Jun 26
PQUS · Weight increase · 2d
MRSH's reported revenue growth of 9.87% and a high ROE of 25.91% contribute to its appeal within Pictet Asset Management's AI ranking system for the PQUS ETF, aligning with its US large-cap style and focus on measured turnover. These fundamental indicators likely supported the AI's decision to incrementally increase the stock's weight, as evidenced by the consecutive rises on June 11 and 12, reaching 0.44%. This increase in allocation transpired while MRSH’s price of $168.15 sat at approximately 72% of its 52-week high, following a 28.0% one-year decline and recent 90-day return of -10.8%. The AI system for PQUS, managing ~165 US large caps with periodic rebalances, likely identified a buying opportunity based on the company's attractive PBR of 5.86 and a PER of 20.66 relative to its reduced market price.
weight 0.420% → 0.440% (+0.020 pp)·stock up 6.0% in the 30 days before
Jun 12·entry $168.68·now $182.10Drifting
+7.96%
since Jun 12
PQUS · Weight increase · 2d
weight 0.400% → 0.430% (+0.030 pp)·stock up 0.9% in the 30 days before
Jun 7·entry $162.52·now $182.10Chased
+12.05%
since Jun 7
PQUS · Sudden change · 1d
The weight of MRSH in PQUS abruptly surged from 0.06% to 0.41% on May 29th after holding steady for a week, marking a distinct, stepped increase rather than a gradual accumulation. This significant reallocation aligns with the ETF's AI ranking system re-evaluating MRSH as its stock price approached the 52-week low of $159.14, following a -28.5% decline over the past year. Despite the price dip, MRSH maintains a revenue growth of 9.87% and a 25.91% return on equity, which likely elevated its standing within the AI's US large-cap universe. Such a sudden, large adjustment fits Pictet Asset Management's strategy for PQUS, a fund which rebalances periodically rather than daily, allowing its concentration rules to accommodate a substantial position change based on updated AI-driven rankings.
weight 0.060% → 0.410% (+0.350 pp)·stock down 6.4% in the 30 days before
May 29·entry $159.97·now $182.10
+13.83%
since May 29
PQUS · New entry · 1d
The AI ETF likely initiated a new position in MRSH due to its strong underlying financial health, evidenced by robust revenue growth and an excellent return on equity, indicating a highly profitable and efficient business. For retail investors, this suggests prioritizing companies with strong and consistent fundamental performance metrics, such as high ROE and revenue growth, as key drivers for long-term portfolio additions.
weight 0 → 0.040% (new)·stock down 5.7% in the 30 days before
May 10·entry $161.58·now $182.10Chased
+12.70%
since May 10
AIEQ · Exit · 1d
The AI ETF likely divested MRSH due to its high valuation multiples (PER 20.4, PBR 5.86) for the financial sector, as its systematic model probably determined the risk-reward profile had become unfavorable despite the company's strong profitability. Retail investors should recognize that even fundamentally sound companies can be subject to rapid divestment by algorithmic strategies when valuation becomes stretched, underscoring the importance of monitoring valuation alongside growth.
weight 0.300% → 0 (exited)·stock down 3.3% in the 30 days before
May 3·entry $167.87·now $182.10
+8.48%
since May 3
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
Buffett-style framework
Fails the frameworkas of May 4
The AI ETF AIEQ recently exited Marsh & McLennan, dropping its weight to zero. This action aligns with the framework's 'Fail' verdict, as the analysis suggests the company is not an attractive investment at its current valuation despite its strong underlying business.
- Circle of CompetenceThe insurance brokerage and consulting business model, based on recurring commissions and service fees, offers stable and predictable unit economics, allowing for reasonable long-term cash flow projections.
- Economic MoatMarsh & McLennan benefits from significant brand recognition, high client switching costs due to integrated service offerings, and global scale in risk management and consulting.
- ManagementWithout information on management communications, a detailed capital allocation track record, or insider ownership beyond general financial outcomes, it is not possible to fully assess management's alignment with shareholder interests.
- Financial HealthWhile the current ROE of 25.91% is strong, the absence of a 10-year average ROE, annual ROE consistency, detailed operating margins, comprehensive debt structure, and owner earnings data prevents a full assessment of long-term financial health per the framework.
- Margin of SafetyBased on the provided valuation multiples (PER 20.4, PBR 5.86, EV/EBITDA 20.1), the current price does not appear to offer a clear margin of safety or a defensible discount to a conservative estimate of intrinsic value.
Marsh & McLennan operates within a predictable circle of competence and possesses a durable economic moat from its strong brands and switching costs. However, a full assessment of management and long-term financial health is constrained by the available data, preventing confirmation of critical financial criteria. Most importantly, the current valuation does not offer a sufficient margin of safety, leading to an overall 'Fail' verdict for a Buffett-style investment.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.